Correlation Between 23Andme Holding and Conduit Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Conduit Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Conduit Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Conduit Pharmaceuticals, you can compare the effects of market volatilities on 23Andme Holding and Conduit Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Conduit Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Conduit Pharmaceuticals.
Diversification Opportunities for 23Andme Holding and Conduit Pharmaceuticals
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between 23Andme and Conduit is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Conduit Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Conduit Pharmaceuticals and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Conduit Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Conduit Pharmaceuticals has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Conduit Pharmaceuticals go up and down completely randomly.
Pair Corralation between 23Andme Holding and Conduit Pharmaceuticals
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to generate 0.61 times more return on investment than Conduit Pharmaceuticals. However, 23Andme Holding Co is 1.64 times less risky than Conduit Pharmaceuticals. It trades about -0.07 of its potential returns per unit of risk. Conduit Pharmaceuticals is currently generating about -0.06 per unit of risk. If you would invest 5,980 in 23Andme Holding Co on September 3, 2024 and sell it today you would lose (5,625) from holding 23Andme Holding Co or give up 94.06% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
23Andme Holding Co vs. Conduit Pharmaceuticals
Performance |
| Timeline |
| 23Andme Holding |
| Conduit Pharmaceuticals |
23Andme Holding and Conduit Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 23Andme Holding and Conduit Pharmaceuticals
The main advantage of trading using opposite 23Andme Holding and Conduit Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Conduit Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Conduit Pharmaceuticals will offset losses from the drop in Conduit Pharmaceuticals' long position.| 23Andme Holding vs. IDEXX Laboratories | 23Andme Holding vs. Twist Bioscience Corp | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Agilent Technologies |
| Conduit Pharmaceuticals vs. DiaMedica Therapeutics | Conduit Pharmaceuticals vs. Lyra Therapeutics | Conduit Pharmaceuticals vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |